Skip to main content
Scienza Health
Clinical AI

Early MCI Detection Without Adding Staff Time in LTC

David Kaiser, Founder & CEO, Scienza Health··Updated March 31, 2026·3 min read
Share

Key Facts

  • 12 million Americans have Mild Cognitive Impairment (MCI). [citation needed]
  • 92% of individuals with MCI are unaware of their condition. [citation needed]
  • Scienza Health's GIA offers cognitive decline detection with 70.8% accuracy.
  • GIA integrates directly with existing EHR systems like PointClickCare and Epic.
  • GIA screens for cognitive decline in under 5 minutes, with results in 60 seconds.

This article discusses how to achieve early detection of Mild Cognitive Impairment (MCI) in long-term care without increasing staff workload. Scienza Health offers a speech-based assessment platform that screens for cognitive decline with 70.8% accuracy, addressing the challenge of early detection using technology that minimizes disruption to the clinical process. Consider that 12.3M patients are living with MCI, and GIA screens for cognitive decline in under 5 minutes.

What is Mild Cognitive Impairment?

Mild Cognitive Impairment (MCI) is a transitional state between normal age-related cognitive changes and dementia, increasing the risk of progressing to dementia. Identifying MCI early enables interventions like lifestyle modifications and cognitive therapies, potentially slowing cognitive decline. Traditional cognitive assessments can be time-consuming, making widespread screening impractical in many long-term care settings, but GIA offers an automated approach.

What is GIA?

GIA is a speech-based assessment platform that screens for cognitive decline with 70.8% accuracy. GIA conducts screenings without direct staff involvement, using Samsung Health Grade Galaxy devices with Samsung Knox for residents to answer questions or complete tasks. The entire process takes under 5 minutes, and results are available within 60 seconds, using over 2,500 speech biomarkers to detect subtle changes in cognitive function. GIA is 510(k) cleared and HIPAA compliant.

FREE GUIDE

The Operator's Guide to Multimodal Clinical AI

What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.

How Does GIA Work?

GIA works by having residents interact with Samsung Health Grade Galaxy devices with Samsung Knox. GIA speaks 92 languages, guiding residents through cognitive assessments and capturing speech data, which is then analyzed to identify patterns of cognitive decline. GIA integrates with EHR systems like PointClickCare, Epic, Cerner, and MatrixCare, allowing for automated data transfer and streamlined documentation; GIA is a screening tool and does not diagnose.

What are the Financial Benefits of Early Detection?

Implementing early MCI detection strategies can offer financial benefits for long-term care facilities by identifying residents at risk of cognitive decline early. Facilities can implement targeted interventions to slow disease progression and potentially reduce the need for more intensive care. GIA supports billing through established CPT codes, including 96127 ($6-10), 96116 ($94-131), and 99309 (~$100), and helps facilities adhere to CMS F-Tag 605.

How Accurate is GIA?

GIA achieves 70.8% accuracy in cognitive decline detection. For Parkinson's screening, GIA achieves an AUC of 0.97. These results are based on extensive clinical data and algorithms that analyze speech patterns and other biomarkers, but further evaluation by a healthcare professional is necessary to confirm a diagnosis. GIA also screens for Depression (81.6% accuracy), PTSD (80.0%), and Anxiety (77.5%).

Why Implement GIA?

Implementing GIA is a strategic investment because it automates cognitive screening, enabling timely interventions and improved care planning. GIA integrates directly with existing EHR systems and can be administered without staff involvement, making it a practical and cost-effective approach. GIA screens for 46 conditions and analyzes over 2,500 speech biomarkers.

Conclusion

Early detection of Mild Cognitive Impairment is important for improving resident outcomes and optimizing care planning in long-term care facilities. Scienza Health's GIA offers a unique approach that enables **early MCI detection without adding staff time**, using advanced technology to screen for cognitive decline with minimal disruption to your team's clinical process. With 12 million Americans living with MCI and 92% unaware, the need for proactive screening has never been greater. Take the first step towards improving resident care and optimizing staff resources by requesting a demo of GIA today. See how our 510(k) cleared, HIPAA compliant approach can transform your approach to cognitive health.

Sources & References

  1. Centers for Medicare & Medicaid Services (CMS). Quality measures and star ratings. cms.gov
  2. Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. alz.org/facts
  3. Scienza Health clinical validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events.
  4. U.S. Food & Drug Administration. 510(k) device clearance database. fda.gov
DK
David KaiserFounder & CEO, Scienza Health

David Kaiser is the Founder and CEO of Scienza Health, where he leads the development of GIA®, a Digital Human® that screens for 46 cognitive and neurological conditions using 2,500+ speech biomarkers in under 5 minutes. The platform is 510(k) cleared, HIPAA compliant, and has been validated on 12.3M patient records and 27B clinical events.

Frequently Asked Questions

How does GIA integrate with our existing Electronic Health Record (EHR) system?

GIA integrates directly with leading EHR systems, including PointClickCare, Epic, Cerner, and MatrixCare. This integration allows for automated transfer of resident data, eliminating manual data entry and ensuring that cognitive screening results are readily available to the care team. The ADL and IADL results are written back to the EHR.

Is GIA a diagnostic tool?

No, GIA is a screening tool, not a diagnostic tool. Further evaluation by a qualified healthcare professional is necessary to confirm a diagnosis and develop an appropriate treatment plan. GIA provides information to guide clinical decision-making, but it does not replace the expertise of a physician.

How long does it take to implement GIA in our facility?

The implementation process for GIA is typically quick and straightforward. The actual time frame may vary depending on the size and complexity of your facility. Our team works to ensure a smooth integration.

Share
PODCASTPrefer to listen?

The Clinical Signal

Hear the latest episode on clinical AI screening in post-acute care.

Schedule a Demo

See what 40 seconds of speech reveals.

See What You're Missing